Lee Nguyen

Dr. Lee Nguyen

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in Current Opinion in Nephrology and Hypertension
Verified
Journal Article
Closed access
MTMaria Clarissa Tio
Maria Clarissa Tio
TSTariq Shafi
Tariq Shafi
XZXiaoqian Zhu
Xiaoqian Zhu
KKKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
ACAlexandre Chan
Alexandre Chan
Lee NguyenLee Nguyen
Lee Nguyen
Purpose of review: Glomerular filtration rate (GFR) is the best index for kidney function and estimated GFR (eGFR) calculated from endogenous filtration markers like serum creatinine and cystatin C is widely used in clinical practice for chronic kidney disease diagnosis and prognostication. We sought to review the evolution of GFR estimating equations, nuances of eGFR interpretation, and utility of eGFR in drug dosing. Recent findings: The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) serum creatinine eGFR equation was recently updated to exclude the race variable and the CKD-EPI creatinine–cystatin C equation demonstrated the highest reliability. Although calculated creatinine clearance by Cockcroft Gault has been traditionally used for drug dosing, the use of eGFR is slowly being adapted by the Food and Drug Administration for pharmacokinetic studies. However, the individual-level accuracy of eGFR using the CKD-EPI 2021 equations remained low, with the distribution of measured GFR at a given eGFR value spanning several CKD stages. Summary: Although current methods of estimating GFR have improved in population measures of reliability, all have significant individual-level inaccuracies that can be an issue when clinical decision-making is contingent on the actual level of GFR. Modern methods of GFR measurements should be made widely available to enhance individualized patient decision-making.

21 September 2021 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
DNDing Quan Ng
Ding Quan Ng
EDEmily Dang
Emily Dang
LCLijie Chen
Lijie Chen
MNMary Thuy Nguyen
Mary Thuy Nguyen
MNMichael Ky Nguyen Nguyen
Michael Ky Nguyen Nguyen
ACAlexandre Chan
Alexandre Chan

23 November 2020 in Journal of Racial and Ethnic Health Disparities
Verified
Journal Article
Closed access
PDF file
JYJason Yamaki
Jason Yamaki
HPHarry Peled
Harry Peled
SMSajen Mathews
Sajen Mathews
DPDavid Park
David Park
MFMina Firoozi
Mina Firoozi
Lee NguyenLee Nguyen
Lee Nguyen

13 November 2022 in Journal of the American Pharmacists Association
Verified
Journal Article
Open access
DNDing Quan Ng
Ding Quan Ng
SJStanley Jia
Stanley Jia
CWCheryl Wisseh
Cheryl Wisseh
CCChristine Cadiz
Christine Cadiz
MNMegan Nguyen
Megan Nguyen
KHKeri Hurley-Kim
Keri Hurley-Kim
The National Institutes of Health All of Us (AoU) Research Program is currently building a database of 1million+ adult subjects. With it, we describe the characteristics of those with documented vaccinations. To describe the sociodemographic, health status, and lifestyle factors associated with vaccinations. This is a retrospective study involving data from the AoU program (R2020Q4R2, N = 315,297). Five vaccine cohorts [influenza, hepatitis B (HBV), pneumococcal <65 years old, pneumococcal ≥65 years old, and human papillomavirus (HPV)] were generated based on vaccination history. The influenza cohort comprised participants with documented influenza vaccinations in electronic health records (EHRs) from September 2017 to May 2018. Other vaccine cohorts comprised participants with ≥1 lifetime record(s) of vaccination documented in the EHR by December 2018. The vaccine cohorts were compared to the overall AoU cohort. Descriptive statistics were generated using EHR- and survey-based sociodemographic, health, and lifestyle information. The SAMBA (0.9.0) R package was utilized to adjust for EHR selection and outcome misclassification biases to infer sources of disparity for pneumococcal vaccinations in older adults. Cohort counts were as follows: influenza (n = 15,346), HBV (n = 6323), pneumococcal <65 (n = 15,217), pneumococcal ≥65 (n = 15,100), and HPV (n = 2125). All vaccine cohorts had higher proportions of White and non-Hispanic/Latino participants compared to the overall AoU cohort. The largest differences were found in pneumococcal age ≥65, with 80.2% White participants compared to 52.9% in the overall study population. Multivariable analysis revealed that race/ethnic disparities in pneumococcal vaccination among older adults were explained by biological sex, income, health insurance, and education-related variables. Racial, ethnic, education, and income characteristics differ across the vaccine cohorts among AoU participants. These findings inform future utilization of large health databases in vaccine epidemiology research and emphasize the need for more targeted interventions that address differences in vaccine uptake.

11 December 2024 in Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
Lee NguyenLee Nguyen
Lee Nguyen
CDCatherine Diamond
Catherine Diamond
Doxycycline is a semi-synthetic antibiotic in the tetracycline family. The three common subtypes of tetracyclines include naturally occurring, semi-synthetic, and new agents. Each subtype shares specific commonalities but is substantially different in various clinical applications. The mechanism of antimicrobial activity is the same across subtypes. The structural changes to the core naphthacene ring do not alter the mechanism of action but are thought to alter the rates of adverse effects and mechanisms of resistance. Tetracyclines as a class are known to cause fixed drug eruptions, but the majority of these adverse effects were associated with naturally occurring tetracyclines. Semi-synthetic tetracyclines have limited reports of fixed drug eruptions. Here, we present a case of fixed drug eruption in a patient who previously had multiple treatment courses with doxycycline. The case involves the use of doxycycline not for the treatment of an infection but as postexposure prophylactic (PEP) antibiotic therapy to prevent the acquisition of a sexually transmitted infection. Doxycycline PEP has been shown to reduce the rate of bacterial sexually transmitted infection in men who have sex with men (MSM). Doxycycline PEP is a single dose taken orally within 24–72 h of unprotected sexual intercourse. The dosing structure allows for ease of adherence but also repeatedly exposes individuals to doxycycline, putting them at risk for adverse events such as fixed drug eruptions, as illustrated by this case report.

29 September 2024 in Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
Miriam Banoub MorkosMiriam Banoub Morkos
Miriam Banoub Morkos
GLGiovani Leon
Giovani Leon
MHMai-Chi Hong
Mai-Chi Hong
JGJoshua Allan Garcia
Joshua Allan Garcia
MBMartin J. Breen
Martin J. Breen
Lee NguyenLee Nguyen
Lee Nguyen
Dalbavancin, a semi-synthetic lipoglycopeptide with an extended half-life that allows for weekly dosing, is currently approved for the treatment of bacterial skin and soft tissue infections caused by susceptible gram-positive organisms. This case report discusses the successful treatment of septic arthritis with dalbavancin in a 38-year-old obese male. Septic arthritis, commonly caused by Staphylococcus aureus and Streptococcus species, was diagnosed in this patient following a mechanical fall that led to worsening shoulder pain. Given the patient’s morbid obesity and concerns about antibiotic penetration, dalbavancin 1500 mg IV biweekly was chosen for its extended half-life and ease of administration. This case underscores dalbavancin’s efficacy in managing septic arthritis in obese patients, offering a convenient alternative to traditional therapies that require a peripherally inserted central catheter (PICC line), frequent dosing, therapeutic monitoring, and prolonged hospital stays. Despite its higher cost, dalbavancin’s advantages include reduced need for PICC lines, additional staff and resources to monitor therapeutic drug levels, and fewer complications, which can offset some expenses. To our knowledge, this is the first documented case investigating the use of dalbavancin for enterococcal septic arthritis with a biweekly dosing regimen.